Evidence map›Paper›PMID 37344746›Full record

ArticleCellular & molecular immunology2023

Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity.

Manuel M Vicente, Inês Alves, Ângela Fernandes, Ana M Dias, Beatriz Santos-Pereira, Elena Pérez-Anton, Sofia Santos, Tao Yang, Alexandra Correia, Anja Münster-Kühnel and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The Role of Glycans in Human Immunity-A Sweet Code.Molecules (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Food for thought: Nutrient metabolism controlling early T cell development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  13. The diverseFrontiers in immunology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Immunometabolism (Cobham, Surrey) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Manuel M Vicentei3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Inês Alvesi3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0002-3914-7101
Ângela Fernandesi3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Ana M Diasi3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Beatriz Santos-Pereirai3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Elena Pérez-Antoni3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Sofia SantosNephrology Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal.
Tao YangInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Alexandra Correiai3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Anja Münster-KühnelInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Afonso R M AlmeidaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Sarina RavensInstitute of Immunology, Hannover Medical School, Hannover, Germany.
Gabriel A RabinovichLaboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad de Buenos Aires, Argentina.
Manuel Vilanovai3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
Ana E SousaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Salomé S Pinhoi3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal. salomep@i3s.up.pt.
Universidade do Porto · PTi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTMedizinische Hochschule Hannover · DEUniversity of Lisbon · PTCentro Hospitalar do Porto · PTConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell development ensures the formation of diverse repertoires of T-cell receptors (TCRs) that recognize a variety of antigens. Glycosylation is a major posttranslational modification present in virtually all cells, including T-lymphocytes, that regulates activity/functions. Although these structures are known to be involved in TCR-selection in DP thymocytes, it is unclear how glycans regulate other thymic development processes and how they influence susceptibility to disease. Here, we discovered stage-specific glycome compositions during T-cell development in human and murine thymocytes, as well as dynamic alterations. After restricting the N-glycosylation profile of thymocytes to high-mannose structures, using specific glycoengineered mice (Rag1

Indexed as

ThymocytesThymus GlandAnimalsGlycosylationHomeodomain ProteinsHumansMicePolysaccharidesReceptors, Antigen, T-CellHomeodomain ProteinsPolysaccharidesReceptors, Antigen, T-CellGlycocalyxInflammationN-glycosylationT-cell developmentThymocytes

Identifiers

PMID37344746
PMCPMC10387478
OpenAlexW4381510392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.